American International Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-26,340
| Closed | -$414K | – | 2976 |
|
|
2024
Q1 | $414K | Sell |
26,340
-226
| -0.9% | -$3.48K | ﹤0.01% | 1750 |
|
|
2023
Q4 | $429K | Buy |
26,566
+425
| +2% | +$5.42K | ﹤0.01% | 1760 |
|
|
2023
Q3 | $333K | Buy |
26,141
+930
| +4% | +$12.8K | ﹤0.01% | 1835 |
|
|
2023
Q2 | $355K | Buy |
25,211
+274
| +1% | +$3.92K | ﹤0.01% | 1855 |
|
|
2023
Q1 | $385K | Buy |
24,937
+3,190
| +15% | +$53.3K | ﹤0.01% | 1750 |
|
|
2022
Q4 | $356K | Buy |
21,747
+360
| +2% | +$5.85K | ﹤0.01% | 1789 |
|
|
2022
Q3 | $396K | Buy |
21,387
+301
| +1% | +$4.72K | ﹤0.01% | 1721 |
|
|
2022
Q2 | $277K | Buy |
21,086
+1,348
| +7% | +$14.9K | ﹤0.01% | 1962 |
|
|
2022
Q1 | $183K | Sell |
19,738
-1,177
| -6% | -$10K | ﹤0.01% | 2293 |
|
|
2021
Q4 | $204K | Sell |
20,915
-625
| -3% | -$11.8K | ﹤0.01% | 2361 |
|
|
2021
Q3 | $732K | Sell |
21,540
-512
| -2% | -$16.3K | ﹤0.01% | 1611 |
|
|
2021
Q2 | $807 | Sell |
22,052
-443
| -2% | -$17.2K | ﹤0.01% | 1626 |
|
|
2021
Q1 | $1.01K | Buy |
22,495
+329
| +1% | +$15.3K | ﹤0.01% | 1455 |
|
|
2020
Q4 | $1.26K | Sell |
22,166
-205
| -0.9% | -$12.2K | ﹤0.01% | 1275 |
|
|
2020
Q3 | $1.15M | Sell |
22,371
-509
| -2% | -$24.9K | 0.01% | 1178 |
|
|
2020
Q2 | $1.37M | Buy |
22,880
+10,465
| +84% | +$560K | 0.01% | 1087 |
|
|
2020
Q1 | $511K | Buy |
12,415
+54
| +0.4% | +$3K | ﹤0.01% | 1425 |
|
|
2019
Q4 | $769K | Buy |
12,361
+389
| +3% | +$18.5K | ﹤0.01% | 1466 |
|
|
2019
Q3 | $406K | Buy |
11,972
+2,580
| +27% | +$76.4K | ﹤0.01% | 1774 |
|
|
2019
Q2 | $212K | Buy |
9,392
+3,786
| +68% | +$88.6K | ﹤0.01% | 2190 |
|
|
2019
Q1 | $130K | Sell |
5,606
-181
| -3% | -$4.74K | ﹤0.01% | 2471 |
|
|
2018
Q4 | $121K | Sell |
5,787
-44
| -0.8% | -$1.08K | ﹤0.01% | 2495 |
|
|
2018
Q3 | $226K | Buy |
5,831
+875
| +18% | +$32.3K | ﹤0.01% | 2353 |
|
|
2018
Q2 | $195K | Sell |
4,956
-319
| -6% | -$9.39K | ﹤0.01% | 2364 |
|
|
2018
Q1 | $106K | Sell |
5,275
-283
| -5% | -$7.17K | ﹤0.01% | 2634 |
|
|
2017
Q4 | $126K | Buy |
+5,558
| New | +$109K | ﹤0.01% | 2601 |
|
Other funds holding DCPH
American International Group's DCPH Position: Q2 2024 in Review
American International Group sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 26,340 shares — an estimated $414K sold.
American International Group first reported a position in DCPH in Q4 2017 and held it in 26 quarters. The position peaked at $1.37M in Q2 2020. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- American International Group reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- American International Group sold 26,340 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $414K.
- American International Group first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 26 quarters.
- American International Group's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.37M in Q2 2020.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.